Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellular Immunity Correlates with YF17D and JE-YF17D Vaccines
NCT05568953Phase 2Unknown
- Sponsor
- Singapore General Hospital
- Start
- Sep 2022
- Primary completion
- Oct 2025
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of 17D yellow fever vaccine, japanese encephalitis chimeric virus vaccine, Japanese encephalitis inactivated vaccine in yellow fever, Japanese encephalitis (JE), sponsored by Singapore General Hospital. Status: unknown.
02
Drugs
17D yellow fever vaccinejapanese encephalitis chimeric virus vaccineJapanese encephalitis inactivated vaccine
03
Conditions
yellow feverJapanese encephalitis (JE)
Beyond the preview
Go deeper on NCT05568953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05568953.